Vallejo Ardila et al. conducted a systematic review and meta-analysis of 11 observational studies involving 3200 patients with non-small cell lung cancer (NSCLC), the most prevalent subtype of lung cancer often characterized by EGFR mutations. This evidence concerns the gene EGFR and non-small cell lung carcinoma.